Caixin Deep Dive: How AstraZeneca’s China Fraud Was About More Than Greed
China Business Insider - News From Caixin Global
Release Date: 11/08/2024
China Business Insider - News From Caixin Global
The ban leaves a legal void, complicating efforts by authorities to dispose of seized digital assets from crimes. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
China’s inclusive finance has expanded rapidly under government push, but banks are caught in a bind — balancing policy goals with mounting risks. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
Under mounting pressure from bad debts at home, Chinese banks are going global — chasing the hidden overseas fortunes of defaulted tycoons. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
China is stepping up its crackdown on destructive “involution-style” competition across a range of key industries, from traditional sectors like steel and cement to emerging sectors such as lithium batteries and new-energy vehicles. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
China’s top economists are locked in a fierce debate over whether the country’s consumers are truly weak or just misunderstood — an argument that could determine whether Beijing bets on households or more heavy industry. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
China’s top economists are locked in a fierce debate over whether the country’s consumers are truly weak or just misunderstood — an argument that could determine whether Beijing bets on households or more heavy industry. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
Caixin collects the views of five prominent policy experts on China’s priorities like innovation and high-quality growth, as the country drafts its next Five-Year Plan amid global uncertainty. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
Chinese companies listed in the U.S. may face tighter regulations as the U.S. securities watchdog seeks to update decades-old rules on foreign private issuers. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
Deflation, tax breaks and industrial shifts are reshaping the country’s fiscal landscape. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineChina Business Insider - News From Caixin Global
Deflation, tax breaks and industrial shifts are reshaping the country’s fiscal landscape. Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on this Caixin story: Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a . Group discounts are available — contact us for a .
info_outlineThe British pharmaceutical giant falsified patient test results to secure insurance coverage for its cancer drug in an effort to boost sales, but the alleged misconduct ended up benefiting some patients.
Note: The conversation segment of this episode was generated using AI and has been edited for accuracy. It is based on a Caixin story:
Cover Story: How AstraZeneca’s China Fraud Was About More Than Greed
Subscribe now to unlock all coverage from Caixin Global and The Wall Street Journal for just $200 a year, enjoying a 66% discount. Group discounts are available — contact us for a customized plan.